ALEXANDRIA GALLUZZI: Open Payments
NPI 1316660509 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,188 in 223 payments from 22 companies in 2025. Trend: 2023 $2,213 · 2024 $2,047 · 2025 $3,188
Food & beverage: $3,158Education: $30
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $680 |
| Janssen Biotech, Inc. | 66 | $617 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $291 |
| Phathom Pharmaceuticals, Inc. | 26 | $274 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $272 |
| PFIZER INC. | 13 | $192 |
| QOL Medical, LLC | 10 | $146 |
| GENZYME CORPORATION | 5 | $115 |
| Lilly USA, LLC | 5 | $85 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
Products named: TREMFYA, VOQUEZNA, RINVOQ, XIFAXAN, LINZESS, VELSIPITY, EOHILIA, DUPIXENT.
Industry payments across NY — which companies pay providers there.
